Michael Gorman

Mike has over 20 years’ experience guiding life science companies in navigating a risk-managed, best-value path from pre-IND to commercialization. With balanced experience as both manufacturer and service-provider, Mike has directed multiple diverse cross-functional teams through the technology transfer process. He helps clients develop strategy and systems for their technology transfer, CMC, manufacturing supply chain, and alliance management programs, so they can nimbly and effectively deliver quality therapeutic products to patients. He works with clients across a spectrum of technologies and modalities, focusing in biologics – including traditional and advanced therapeutic cell and gene therapies.